NovaFRA:NMR -9.57%93 EBITDA Margin % is 32.57% as of Mar. 2026, which is 13% above its 10-year median of 28.75. GuruFocus rates FRA:NMR with a GF Score™ of 93/100 and a GF Value™ of €268.91 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,023 Semiconductors companies, Nova ranks better than 85.63% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nova's EBITDA for the
three
months ended in Mar. 2026 was €66.3 Mil. Nova's Revenue for the
three
months ended in Mar. 2026 was €203.5 Mil. Therefore, Nova's EBITDA margin for the quarter that ended in Mar. 2026 was 32.57%.
Nova (FRA:NMR) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Nova EBITDA Margin % Related Terms
Nova EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Nova's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:NMR vs AMKR, ONTO, ENTG: EBITDA Margin % Comparison
For the Semiconductor Equipment & Materials subindustry, Nova's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova EBITDA Margin % vs Semiconductors Industry
For the Semiconductors industry and Technology sector, Nova's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Nova's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova (FRA:NMR) has a EBITDA Margin % of 32.57% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nova and its competitors. This is 13% above median its historical median of 28.75. Over the past decade, Nova's EBITDA Margin % has ranged from 10.23 to 31.51. According to the industry distribution chart, Nova ranks #147 out of 1023 companies in the Semiconductors industry, placing it in the top 14.4%.
Is Nova's EBITDA Margin % too high?
Nova's current EBITDA Margin % of 32.57% is 13% above median its 10-year median of 28.75. Over the past 10 years, this metric has ranged from a low of 10.23 to a high of 31.51. The Semiconductors industry median EBITDA Margin % is 10.52. Nova's value of 32.57% is 209.6% above this industry median. Based on the distribution chart, Nova ranks #147 out of 1023 companies in the Semiconductors industry, which is in the top quartile — a strong position relative to peers. Overall, Nova has a GF Score™ of 93/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova's EBITDA Margin % compare to AMKR and ONTO?
According to the Semiconductors industry distribution chart, Nova ranks #147 out of 1023 companies for EBITDA Margin %. This places Nova in the top 14% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.52. Nova's value of 32.57% is 209.6% above this benchmark. Historically, Nova's own EBITDA Margin % has ranged from 10.23 to 31.51 over the past decade. While the company's 10-year median is 28.75 vs. the industry median of 10.52, Nova has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Semiconductors company?
The median EBITDA Margin % among Semiconductors companies is 10.52, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova's current EBITDA Margin % of 32.57% is 209.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nova and its competitors. For the Semiconductors industry, the median EBITDA Margin % is 10.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova's current EBITDA Margin % is 32.57%, which is 13% above median its own 10-year median of 28.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova stock overvalued right now?
Based on GuruFocus' analysis, Nova (FRA:NMR) is currently considered Significantly Overvalued. The stock's GF Value™ is €268.91, compared to a current price of €427.00 — trading 58.8% above its estimated fair value. The current EBITDA Margin % is 32.57%, which is 13% above median its 10-year median of 28.75 and 209.6% above the Semiconductors industry median of 10.52. Nova's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Nova (FRA:NMR), the current EBITDA Margin % is 32.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova (FRA:NMR) Overvalued in 2026?
Based on GuruFocus' analysis, Nova stock appears to be overvalued.
The current stock price of €427.00 is trading 58.8% above its estimated GF Value™ of €268.91.
GuruFocus considers Nova to be Significantly Overvalued.
Key valuation signals for FRA:NMR:
EBITDA Margin %: 32.57% (13% above median its 10-year median of 28.75)
GF Value™: €268.91 vs. price of €427.00 (58.8% above fair value)
Industry Position: 209.6% above the Semiconductors median (#147 of 1023)
No single metric tells the full story. See the FRA:NMR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.
93GF Score
Get the complete analysis for FRA:NMR
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NMR has been successfully added to your 
